Valeant Pharmaceuticals said it will buy Salix Pharmaceuticals for $10 billion. The Quebec-based company said it would pay $158 per share for Salix. The deal will take Valeant into the multibillion dollar market for drugs treating stomach disorders like traveler's…
That total on the balance sheet has been the focus of speculation among investors ever since the New York-based pharmaceutical company walked away from an almost $120 billion deal to acquire U.K. drugmaker AstraZeneca Plc last year. The use of…
The dollar's surge is reducing earnings at American companies from Procter & Gamble Co. to Pfizer Inc. and DuPont Co. that make a large portion of their revenue abroad. P&G, the world's biggest consumer-products maker, today reported profit that missed…
Johnson & Johnson ($JNJ) isn't the only company with a hepatitis C drug operating in the shadow of new giants from Gilead Sciences ($GILD) and AbbVie ($ABBV). Merck & Co.'s Victrelis, a breakthrough product when it made its debut in…
GlaxoSmithKline ($GSK) is struggling to grow sales post-China bribery scandal, cutting jobs in the U.S. while focusing on a long-term overhaul to manufacturing and R&D to chart some upward momentum. The company was said to be exploring job cuts in…
Celgene's ($CELG) Abraxane is one of those cancer fighters that has proven effective against many forms of cancer, and so the company has sought approvals far and wide, sometimes successfully and other times not. Now it has been recommended in…
The World Health Organization says at least 8,153 people have died in the Ebola outbreak in West Africa. The Geneva-based body said Monday (01/05/2015) that the total number of confirmed, probable and suspected deaths from the disease comes from 20,656…